Wednesday, May 15, 2024
Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer, Phase III study finds
medicalxpress.com/news/2024-05-pre-surgical-immunotherapy-outcomes-patients.html
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment